International Fuel Technology, Inc. Receives “No Harm” Certification From The AGQM For PerfoLiFT™ BD-4
The PerfoLiFT™ BD-Series is a group of scientifically engineered liquid fuel additive formulations specifically designed to provide superior oxidation stability, long term storage stability, and deposit formation control to bio-diesel and bio-diesel fuel blends.
The Association for the Quality of Bio-diesel, or AGQM (its German acronym), is an independent German-based organization formed in 1999 to monitor the quality of bio-diesel. Though not an official international specification, the AGQM’s “No Harm and Relative Efficiency” certification has become the de facto standard of reference for the qualification of stabilizers meeting the demanding requirements of the bio-diesel industry. A large and increasing number of bio-diesel producing countries now require the AGQM “No Harm” certification for products entering their bio-diesel oxidation stabilizer markets.
“With both PerfoLiFT™ BD-3 and PerfoLiFT™ BD-4 now being certified under the coveted “No Harm” program from the AGQM, it is clear signal that our PerfoLiFT™ BD-Series of additives is well positioned to capitalize on the growing consumption of bio-diesel worldwide and a strong message to the industry regarding the efficacy of our technology,” said Axel Farhi, IFT’s Director of Global Business Development. “The PerfoLiFT™ BD-Series can be tailor made to address stability issues associated with bio-diesel source materials of any kind. We believe we have one of the top performing, if not the top performing, series of fuel additive formulations for providing superior oxidation stability, long term storage stability, and deposit formation control to bio-diesel and bio-diesel fuel blends.”
Note
Statements contained in this web site that are not strictly historical are forward-looking within the meaning of the safe harbor clause of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties that may cause the Company's actual results to differ materially from such forward-looking statements. These risks and uncertainties include, but are not limited to, demand for the Company’s product both domestically and abroad, the Company's ability to continue to develop its market, general economic conditions and other factors that may be more fully described in the Company’s literature and any periodic filing with the Securities and Exchange Commission.